This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Universitetet I Oslo. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Magnus Aronsen: Innovator in Cardiac Treatment
Introduction
Magnus Aronsen is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of cardiac treatment through his innovative patents. With a total of 2 patents, Aronsen's work focuses on addressing critical health issues related to heart failure and cardiac remodeling.
Latest Patents
Aronsen's latest patents include inhibitors of ADAMTS4 or ADAMTS5 for use in preventing or treating cardiac remodeling and chronic heart failure. These inventions provide a method for treating or preventing cardiac remodeling or heart failure in subjects at risk. The patents detail the administration of a therapeutically effective amount of an inhibitor of an ADAMTS proteoglycanase, which can be manufactured into a medicament for these purposes.
Career Highlights
Aronsen is affiliated with the University of Oslo, where he continues to advance research in cardiac health. His work is pivotal in developing new therapeutic strategies for heart-related conditions, showcasing his commitment to improving patient outcomes.
Collaborations
Some of his notable coworkers include Maria Vistnes and Geir Christensen, who contribute to the collaborative efforts in research and development at the University of Oslo.
Conclusion
Magnus Aronsen's innovative work in cardiac treatment through his patents highlights his dedication to addressing significant health challenges. His contributions are essential in the ongoing fight against heart disease and improving the quality of life for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile